Skip to content

Web Based Investigation of Natural History of Keloid Disorder, an Online Survey

Web Based Investigation of Natural History of Keloid Disorder, an Online Survey

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01423981
Enrollment
10000
Registered
2011-08-26
Start date
2011-11-30
Completion date
2031-06-30
Last updated
2016-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid

Keywords

Keloid, Scar, hypertrophic scar, familial keloid

Brief summary

This trial intends to gather very basic clinical information about keloid, its patterns of presentation, family history, ethnic background and correlation with the type of keloid, as well as prior treatment results that patients have had received.

Detailed description

This will be a web based study, whereby patients will have to read and acknowledge the consent form online. Once patients agree and acknowledge the terms of the consent form, they will gain access to the questionnaire pages. For those who are under age of 18, a parent or a legal guardian must sign the consent form and answer the online questions on behalf of the patient.

Interventions

None listed

Sponsors

Tirgan, Michael H., M.D.
Lead SponsorINDIV

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients must have clinically confirmed diagnosis of keloid 2. Adults, age over 18 3. Parent or legal guardian may participate if patient is under the age of 18 4. Able and willing to complete a web based survey

Exclusion criteria

* No one will be excluded from this study as long as the inclusion criteria are met.

Design outcomes

Primary

MeasureTime frameDescription
Determine the prevalence different phenotypes of keloid in participants.Two yearsPrevalence of different phenotypes of keloid will be measured in the study population and reported. Prevalence of familial keloid in the study population will also be determined and reported. Data will be analyzed to determine the distribution of keloid among different ethic groups. Data will be analyzed to report the percentage of patients who have had one or more treatments and the percentage of patients who have had successful treatments.

Countries

United States

Contacts

Primary ContactMichael H Tirgan, MD
htirgan@gmail.com(212) 874 4200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026